PSA DOUBLING TIME AS PREDICTOR OF OBJECTIVE PROGRESSION AND DEATH IN PATIENTS WITH T0-4 N0-2 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL DEFINITIVE TREATMENT ON WATCHFUL WAITING (EORTC 30891)

Authors :: Peter Whelan
L. Collette
Urs E. Studer
Santiago Isorna
T.M. De Reijke
D. Hauri
Walter Albrecht
Subramanian K. Sundaram
Muriel Debois
Wolfgang Loidl
Jacques Casselman
Source :: European Urology Supplements. 5:203
Publication Year :: 2006
Publisher :: Elsevier BV, 2006.

Subjects :: Oncology
medicine.medical_specialty
Prostate cancer
business.industry
Urology
Internal medicine
medicine.medical_treatment
Medicine
Doubling time
In patient
business
medicine.disease
Watchful waiting

Full Text Access

Tools